KIT and gastrointestinal stromal tumor: Of note, a similar pattern was observed for GIST-T1 cells treated with low (0.02 μM) concentrations of IM, whereas presence of anti-FGF2 mAbs abrogated activation of VEGFR signaling in KIT-inhibited GIST (Figure 2).